723MO Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study

I.B. Vergote; B.J. Monk; R.E. O’Cearbhaill; A.M. Westermann; S. Banerjee; D.C. Collins; M.R. Mirza; D. O'Malley; C. Gennigens; S. Pignata; B. Melichar; A. Sadozye; F. Forget; K.S. Tewari; E. Gort; I. Soumaoro; C. Mondrup Andreassen; L.V. Nicacio; E. Van Nieuwenhuysen; D. Lorusso

doi:10.1016/j.annonc.2021.08.1166

Back

723MO Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study

Journal article

Open access

Peer reviewed

723MO Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study

I.B. Vergote, B.J. Monk, R.E. O’Cearbhaill, A.M. Westermann, S. Banerjee, D.C. Collins, M.R. Mirza, D. O'Malley, C. Gennigens, S. Pignata, …

Annals of oncology, Vol.32, pp.S726-S727

09/2021

DOI: https://doi.org/10.1016/j.annonc.2021.08.1166

Files and links (1)

url

https://doi.org/10.1016/j.annonc.2021.08.1166View

Published (Version of record) Open

Metrics

7 Record Views

Details

Title: 723MO Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study
Creators: I.B. Vergote - The European Academy of Gynaecological Surgery
B.J. Monk - The US Oncology Network
R.E. O’Cearbhaill - Memorial Sloan Kettering Cancer Center
A.M. Westermann - Academic Medical Center
S. Banerjee - Royal Marsden NHS Foundation Trust
D.C. Collins - Medical Oncology, Cork University Hospital/Oncology Trials Unit, Cork, Ireland
M.R. Mirza - Copenhagen University Hospital
D. O'Malley - The Ohio State University
C. Gennigens - Centre Hospitalier Universitaire de Liège
S. Pignata - Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
B. Melichar - Palacký University Olomouc
A. Sadozye - NHS Greater Glasgow and Clyde
F. Forget - Medical Oncology, Centre Hospitalier de l'Ardenne, Libramont, Belgium
K.S. Tewari - University of California, Irvine Medical Center
E. Gort - University Medical Center Utrecht
I. Soumaoro - Genmab
C. Mondrup Andreassen - Biostatistics, Genmab A/S, Copenhagen, Denmark
L.V. Nicacio - Seagen
E. Van Nieuwenhuysen - The European Academy of Gynaecological Surgery
D. Lorusso - Agostino Gemelli University Polyclinic
Publication Details: Annals of oncology, Vol.32, pp.S726-S727
Publisher: Elsevier Ltd
Identifiers: 991005969021902656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article